Inferior Vena Cava Filter Use in the Setting of Gastrointestinal Blood Loss, Malignancy, and Multiple Thromboembolisms: A Case Report.
deep vein thrombosis (dvt)
malignancy-associated hypercoagulability
primary colorectal cancer
pulmonary embolism (pe)
retrievable inferior vena cava filter
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
accepted:
20
08
2022
entrez:
26
9
2022
pubmed:
27
9
2022
medline:
27
9
2022
Statut:
epublish
Résumé
Cancer-associated thromboembolism (CAT) is a common yet serious condition that occurs due to the physiological changes brought about by malignancy. The two conditions that are the most prevalent are deep vein thrombosis (DVT) and pulmonary embolism (PE). Anticoagulation is the standard of care for these thrombotic problems, however, in the event these medications are contraindicated, other treatment modalities may be needed. One common example is in the setting of an active bleed, such as gastrointestinal (GI) cancer. A treatment that has been used more frequently in recent years is the inferior vena cava (IVC) filter. These can be placed to provide a physical barrier to prevent a thrombus from moving through the circulation and potentially embolizing critical organs. An advantage of these devices is that they can be placed and removed when the use of pharmacological agents is better indicated. This report is a good example of a situation where an active GI malignancy created a hypercoagulable state leading to multiple thromboembolisms. An IVC filter was placed in the perioperative setting to prevent further thrombus migration while the primary malignancy was cured with a hemicolectomy.
Identifiants
pubmed: 36158360
doi: 10.7759/cureus.28212
pmc: PMC9484811
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e28212Informations de copyright
Copyright © 2022, Ahmann et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JAMA Netw Open. 2020 Jul 1;3(7):e2011079
pubmed: 32701160
J Med Vasc. 2020 Nov;45(6S):6S8-6S16
pubmed: 33276943
J Natl Compr Canc Netw. 2021 Oct 15;19(10):1203-1210
pubmed: 34666314
Adv Clin Chem. 2021;105:213-242
pubmed: 34809828